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shows results of tests for conventional steroids. Table 2 shows results of GLC using high-resolution glass capillary columns for the simultaneous determination of urinary steroids (Ros & Sommerville 1971) . Operation (11.3.70): Both ovaries enlarged and polycystic. Bilateral ovarian split performed; solid tumour (1 x 1 x 1 cm) enucleated from right ovary. Histology confirmed arrhenoblastoma. Table 3 shows results of operative samples. Postoperative progress: The patient started menstruating one month after operation and has had regular periods since then. There has been minimal change in the hirsuties. Plasma and urinary testosterone levels fell into the normal range and have remained so.
Discussion
The clinical picture of marked virilism suggested the presence of an ovarian or adrenal tumour. The high plasma testosterone levels which failed to suppress with dexamethasone or rise with ACTH, together with the 17-oxosteroid excretion at the upper limit of normal, strongly indicated an ovarian tumour. Operation revealed bilateral 9 785 polycystic ovaries and, in view of the biochemistry, bilateral ovarian split was performed, revealing an arrhenoblastoma in the right ovary. Relatively little information is available on arteriovenous steroid differences across the normal or pathological ovary. Horton et al. (1966) measured androstenedione and testosterone during ovariectomy for breast cancer and found mean ovarian to peripheral vein ratios to be 6.5:1 for androstenedione and 1.5:1 for testosterone. This compares with an ovarian vein to artery ratio in our patient, across the polycystic ovary containing the tumour, of 11:1 for androstenedione and 14:1 for testosterone.
The failure of dexamethasone to suppress urinary 17-oxogenic steroids before operation is probably explained by the non-suppressible, elevated urinary pregnanetriol, presumably of ovarian origin. The raised urinary pregnanediol level two months after operation indicated that the patient had ovulated.
Corral-Gallardo et al. (1966) described a 22year-old girl with primary amenorrhoea and virilization who had bilateral polycystic ovaries and a hilar cell tumour in one ovary. The patient first noted hirsuties at age 11. This tumour was thought to be unique in its association with polycystic ovaries but one of the patients described by Allen & Woolf (1959) with polycystic ovaries also had a hilar cell tumour. A further 3 cases were described by Zourlas & Jones (1969), all of whom showed virilization at puberty. At operation all had polycystic ovaries and, in addition, one had an arrhenoblastoma, another an interstitial cell tumour of the ovary and the third an adrenal rest tumour. The association of polycystic ovaries with virilizing adrenal disease has been reviewed by Prunty (1967) . It is of interest that our patient first noticed hirsuties at puberty, and it is tempting to speculate that the tumour was present then or earlier, leading to hypothalamic exposure to androgen at a critical period of time, and that this produced the polycystic ovary syndrome. This situation is known to occur in rats, where injection of a single dose of testosterone in the first ten days of life induces subsequent anovulatory sterility and the polycystic ovary syndrome (Barraclough 1961 , Flerko 1971 Diabetic Ketosis with Gross Hyperlipoproteinmmia and followed by Severe Peripheral Neuropathy Anne Kilby MB (for Oliver Garrod MD FRCP) (Barnet General Hospital, Wellhouse Lane, Barnet, Hertfordshire) T P, male aged 16 History: Admitted in a moribund condition, having felt unwell for three days although more thirsty than normal for past few months. No previous history of diabetes. One week earlier he had developed a rash over arms, thighs and trunk. On admission: Deeply unconscious, with irregular respiration and having inhaled vomitus; cold, sweating and cyanosed. Papular rash of small nodules, some pearly white and others haemorrhagic, on buttocks, chest and extensor surfaces of arms and legs. Fundal examination revealed lipoemia retinalis. A catheter specimen of urine showed heavy glycosuria and acetonuria. Investigations: Blood glucose 520, serum cholesterol 1800 mg/100 ml; serum triglycerides 7.9 g/ 100 ml. Serum milky. Astrup test of femoral arterial blood pH 6.92, base excess -24, Pco2 34.4; standard bicarbonate 7, plasma sodium 125, potassium 2.5, chloride 85 mEq/l; urea 40 mg/ 100 ml. (Initial electrolyte estimations were performed on unseparated plasma, but subsequent ones were performed on plasma from which lipid was first extracted using ether.) Chest X-ray showed changes in right upper lobe compatible with aspiration pneumonia.
The patient's diabetic ketoacidosis was steadily brought under control within 36 hours; however, he remained comatose for three days. Unconsciousness began to lighten by the eleventh day and he was fully conscious by eighteen days, when there were signs of an extensive peripheral neuropathy with loss of all sensory modalities up to elbow and knee, muscular wasting with severe weakness, and loss of deep tendon reflexes. This neuropathy gradually improved over the next four months to leave little residual disability.
Despite high doses of intravenous potassium from the start, his plasma level was difficult to maintain and high urinary potassium outputs of up to 290 mEq/24 h were recorded over the first seven days. On the fifth day of admission he went into cardiac asystole several times. Subsequently he required positive pressure ventilation for seven days. The serum lipids fell rapidly towards normal levels, serum cholesterol being 390 mg/100 ml on the third day. The eruptive xanthomata and lipwmia retinalis resolved in one week.
Comment
Hyperlipoproteinwmia and neuropathy are wellrecognized complications of diabetes. This patient showed particularly high levels of serum lipids and a severe neuropathy.
